| Popis: |
Introduction In a videotaped interview for the Wood library Museum, Burnell R. Brown MD, PhD, FFARCS, reflected on his career filled with many significant achievements. He felt that he had done five things of significance to society: promoting the use of alpha blockers in pheochromocytoma, founding and nourishing the department at the University of Arizona, working out the pathophysiology of halothane hepatotoxicity, editing the Survey of Anesthesiology and the textbook General Anaesthesia, Fifth Edition, and introducing sevoflurane to the US market.** The purpose of this essay is to describe Dr. Brown’s role in the introduction of sevoflurane. This was his final achievement prior to his premature death at age 61 (August 8, 1995) from a highly anaplastic carcinoma of obscure origin. (Figure 1) |
Full Text from ScienceDirect